Rewriting the Organic Chemistry Textbooks
Organic chemistry scientists have discovered a big problem and it's almost 100 years old.
Carbon molecules are characteristics by having very specific shapes and arrangements of atoms. The double bonds between molecules are called alkenes or olefins. The atoms and all those attached to them are usually in the same plane. Molecules that are not on the same plane are uncommon. The rule that scientists claim doesn't fit anymore is called Bredt's rule. It was originally reported in 1924.
The overall description is understood as molecules cannot have a carbon-carbon bond at the ring junction of a bridged bicyclic molecule. This is referred to as a "bridgehead" position. The double bond of these structures would have distorted shapes that are different from the rigid shapes of alkenes.
Bredt's rule has limited the usefulness of this kind of synthetic molecule in pharmaceutical research. However, a paper in the journal Science by UCLA scientists is changing that idea. The paper explains how to make several kinds of molecules that violate Bredt's rule, called anti-bredt olefins or ABOs.
Neil Garg is corresponding author and the Kenneth N. Trueblood Distinguished Professor of Chemistry and Biochemistry at UCLA. He explains, "People aren't exploring anti-Bredt olefins because they think they can't. We shouldn't have rules like this or if we have them they should only exist with the constant reminder that they are guidelines not rules. It destroys creativity when we have rules that supposedly can't be overcome."
Garg's lab used molecules called silyi (pseudo) halides. They applied a fluoride source to induce an elimination reaction. This forms ABOs. ABOs are very unstable, so scientists combined another chemical that trapped the unstable molecules and made products that can be isolated. The reaction that resulted showed that ABOs can be created and trapped to give the structures some practical value.
Garg summarizes, "There's a big push in the pharmaceutical industry to develop chemical reactions that give three dimensional structures like ours because they can be used to discover new medicines. What this study shows is that contrary to one hundred years of convention, chemists can make and use anti-Bredt olefins to make value-added products."

Comments
Post a Comment